1208551005: Product containing precisely alogliptin (as alogliptin benzoate) 6.25 milligram/1 each conventional release oral tablet (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Hydrolase inhibitor-containing product\Peptide hydrolase inhibitor-containing product\Dipeptidyl peptidase IV inhibitor-containing product\Alogliptin-containing product\...
• \Alogliptin only product\Alogliptin only product in oral dose form\Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet
• \Alogliptin-containing product in oral dose form\Alogliptin only product in oral dose form\Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Pyrimidine-containing product\Alogliptin-containing product\...
• \Alogliptin only product\Alogliptin only product in oral dose form\Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet
• \Alogliptin-containing product in oral dose form\Alogliptin only product in oral dose form\Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet
• \Product manufactured as oral dose form\Alogliptin-containing product in oral dose form\Alogliptin only product in oral dose form\Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet

Status: current, Defined. Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4965106010	Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core
4965107018	Product containing precisely alogliptin (as alogliptin benzoate) 6.25 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start